Orchestra BioMed Holdings Inc
OBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$310.48M
Close$
$-0.01
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $310.48 Million |
|---|---|
| Enterprise Value | $311.78 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.11 |
| Beta | 0.5 |
| Outstanding Shares | 63,812,098 |
Return
| Return on Equity | -201.51% |
|---|---|
| Return on Assets | -51.24% |
| Return on Invested Capital | -58.10% |
Valuation & Multiples
| P/E Ratio | -5.24 |
|---|---|
| PEG | -23.09 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 9.75 |
| Enterprise Value to EBIT | -5.25 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
$254,429
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$133,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 43.57% |
|---|---|
| Total Calls | 15,300▼ 59.84% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 36.82%▼ 19.70% |
|---|---|
| Total Invested | $98.19M▲ 9.02% |
| Investors Holding | 660% |
ESG Score
No data
About Orchestra BioMed Holdings Inc
4 employees